Which heart failure patients benefit most from non-invasive telemedicine? An overview of current evidence and future directions.

ABSTRACT: Telemedicine in heart failure (HF) management may positively impact health outcomes, but varied effects in studies hinder guidance in HF guidelines. Evidence on the effectiveness of telemedicine in HF subpopulations is limited. We conducted a scoping review to evaluate and synthesise evidence on the effectiveness of telemedicine across HF subpopulations that could guide telemedicine strategies in routine practice. Meta-analyses concerning randomised controlled trials (RCTs) with subgroup analyses on telemedicine effectives were identified in PubMed. We identified 15 RCTs, encompassing 21 different subgroups based on characteristics of HF patients. Findings varied across studies and no definite evidence was found about which patients benefit most from telemedicine. Subgroup definitions were

SUBMITTER: van Eijk J 

PROVIDER: S-EPMC11336005 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature